Particle.news

Download on the App Store

Benadryl Challenge Still Endangering Teens, Researchers Report at AAP 2025

A preliminary FDA case review logged 413 diphenhydramine incidents in ages 10 to 25 with peaks in 2020 and 2023.

Overview

  • Researchers say the challenge’s periodic resurgence across platforms keeps driving teen diphenhydramine misuse that can cause arrhythmias, seizures, coma and death.
  • FDA adverse-event data show spikes in July and December 2020, July 2021, February and May 2023, and January and June 2024 among ages 10–25.
  • A South Carolina 13-year-old was treated this month for hallucinations and a heart rate near 200 bpm after taking Benadryl to get high, local news reported.
  • The FDA warned in 2020 to secure diphenhydramine at home, and researchers urge renewed education and tighter platform moderation.
  • Authors emphasize that the conference data are preliminary pending peer-reviewed publication.